2.74
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché PHIO Giù?
Forum
Previsione
Frazionamento azionario
Phio Pharmaceuticals Corp Borsa (PHIO) Ultime notizie
PHIO Stock’s Unexpected Rise: What’s Next? - timothysykes.com
Phio Pharmaceuticals Secures $2.5M Financing: New Warrant Structure Strengthens Cancer Drug Development - Stock Titan
Phio Pharmaceuticals Announces New Manufacturing Agreement - TipRanks
Phio Pharmaceuticals Corp. Stock Analysis and ForecastConsistent wealth multiplication - PrintWeekIndia
Clinical Trial Success: Phio's Cancer Drug Shows 100% Tumor Clearance in Latest Results - Stock Titan
PHIO’s Unexpected Climb: What’s Driving the Surge? - StocksToTrade
Phio Pharmaceuticals stock soars after manufacturing agreement - Investing.com
Phio Pharmaceuticals signs manufacturing agreement for cancer drug - Investing.com Australia
Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance - Newsfile
Phio Pharmaceuticals Advances Cancer Drug Production with Strategic US Manufacturing Partnership - Stock Titan
Is Phio Pharmaceuticals Corp. a good long term investmentBreakout stock performance - jammulinksnews.com
What analysts say about Phio Pharmaceuticals Corp. stockUnmatched market performance - Autocar Professional
What drives Phio Pharmaceuticals Corp. stock priceSuperior returns - jammulinksnews.com
Phio Pharmaceuticals shares rise 1.26% premarket after closing a public offering of 10,000,000 shares. - AInvest
Stocks in play: Mogo Inc. - The Globe and Mail
3 Streaming Stocks to Watch as Subscribers Drive Growth - The Globe and Mail
Why Phio Pharmaceuticals Corp. stock attracts strong analyst attentionHigh Reward Risk Balanced Trading - Newser
What makes Phio Pharmaceuticals Corp. stock price move sharplySmart Growth Low Risk Picks - Newser
How Phio Pharmaceuticals Corp. stock performs during market volatilityFree Financial Group - Newser
Petro-Victory Energy provides update on the conclusion of drilling the AND-5 well in the 100% owned Andorinha field, onshore, Brasil - The Globe and Mail
Phio Pharmaceuticals Announces 2025 Annual Meeting Details - The Globe and Mail
Phio Pharmaceuticals (NASDAQ:PHIO) Stock Price Up 6.3% – Here’s Why - Defense World
OSBC EVP adds 16 shares; total insider holding tops 107k | PHIO SEC FilingForm 8-K - Stock Titan
Why AstraZeneca Stock Topped the Market on Tuesday - The Globe and Mail
Phio Pharma stock maintains buy rating as cancer trial advances - Investing.com
Phio’s PH-762 shows positive safety profile in fourth cohort trial - Investing.com
Breakthrough: Phio's Skin Cancer Treatment Shows Positive Results in Phase 1b Trial, CEO Details Progress - Stock Titan
Phio Pharmaceuticals Announces Strategic Initiative and Leadership Changes - TipRanks
Phio Pharmaceuticals Appoints Lisa Carson As Principal Financial OfficerSEC Filing - MarketScreener
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):